• Zosano Pharma (NASDAQ:ZSAN) Upgraded to Buy at Zacks Investment Research

    Zacks Investment Research upgraded shares of Zosano Pharma (NASDAQ:ZSAN) from a hold rating to a buy rating in a research note released on …

    Read More
  • 0 0